CEL SCI CORP (CVM) AI Stock Price Forecast & Investment Analysis
Latest Analysis Date: August 22, 2025
CEL SCI CORP (CVM) - Comprehensive Stock Analysis & Investment Research
Company Overview & Business Profile
CEL SCI CORP (Stock Symbol: CVM)
is a leading company in the Life Sciences sector
, specifically operating within the Biological Products, (No Diagnostic Substances) industry.
The organization employs approximately 14 professionals worldwide
.
The company has established itself as
an emerging investment opportunity with substantial growth potential.
Financial Performance & Key Metrics Analysis
Market Capitalization: $51 million - Classified as a
small-cap investment offering high growth potential.
Return on Equity (ROE): -96.7% -
Below-average
shareholder return efficiency, indicating areas for operational improvement.
Advanced AI Stock Prediction & Price Target Analysis
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for CEL SCI CORP stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Market Position & Competitive Advantage Analysis
CEL SCI CORP strategically competes in the highly dynamic
Biological Products, (No Diagnostic Substances) marketplace,
representing an emerging small-cap investment with substantial growth potential and market disruption capabilities
.
.
CEL SCI CORP Stock Price Chart and Technical Analysis
Loading chart data...
Loading CEL SCI CORP interactive price chart and technical analysis...
Deep dive into CEL SCI CORP's financial health, valuation metrics, and operational efficiency to make informed investment decisions.
Understanding Valuation Metrics
What these metrics mean: Valuation metrics help determine if CEL SCI CORP stock is fairly priced compared to its earnings, assets, and market position.
How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.
For CEL SCI CORP: With a P/E ratio of -0.93, the market sees the stock as potentially undervalued.
P/E Ratio-0.93x
P/B Ratio7.21x
Market Cap$51M
EPS$-0.18
Book Value/Share$1.32
Revenue/Share$-0.05
FCF/Share$-0.48
Understanding Profitability Metrics
What these metrics mean: These ratios measure how efficiently CEL SCI CORP converts revenue into profit and generates returns for shareholders.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For CEL SCI CORP: An ROE of -96.7% indicates room for improvement in shareholder value creation.
ROE-96.7%
ROA-64.0%
ROIC-67.2%
Operating Margin-35786.2%
Net Margin-29526.7%
EBT Margin-392.8%
Understanding Financial Health Metrics
What these metrics mean: These ratios assess CEL SCI CORP's ability to meet short-term obligations and manage debt levels effectively.
How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.
For CEL SCI CORP: A current ratio of 8.33 indicates strong liquidity.
Current Ratio8.33x
Quick Ratio7.66x
D/E Ratio0.32x
Financial Leverage1.42x
Interest Coverage-29.4x
Working Capital$13M
Understanding Cash Flow Metrics
What these metrics mean: Cash flow metrics reveal CEL SCI CORP's ability to generate cash from operations and fund growth initiatives.
How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.
For CEL SCI CORP: Free cash flow of $-21M indicates cash challenges that need attention.
Operating Cash Flow$-18M
Free Cash Flow$-21M
Capital Spending$-3M
FCF/Sales-519.3%
CapEx/Sales52.5%
Understanding Operational Efficiency Metrics
What these metrics mean: These ratios measure how effectively CEL SCI CORP uses its assets and manages working capital.
How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.
For CEL SCI CORP: An asset turnover of 0.01x suggests room for improvement in asset utilization.
Asset Turnover0.01x
Receivables Turnover0.8x
Inventory Turnover2.7x
Fixed Assets Turnover0.3x
Days Sales Outstanding442 days
Days Inventory135 days
Payables Period641 days
Cash Conversion Cycle-398 days
Understanding Financial Statement Data
What these metrics mean: Key figures from CEL SCI CORP's income statement and balance sheet showing absolute financial performance.
How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.
For CEL SCI CORP:
Income Statement ($ Millions)
R&D Expense$19M
SG&A Expense$697M
Cost of Goods Sold$-3M
Balance Sheet Highlights ($ Millions)
Total Current Assets$58M
Cash & Short-term Investments$53M
Total Liabilities$30M
Short-term Debt$4M
Accounts Receivable$0M
Inventory$3M
Dividend & Shareholder Information
Shares Outstanding5M
Growth Metrics (YoY)
EPS Growth-26.9%
CEL SCI CORP (CVM) Fundamental Analysis & Insider Trading Data
(Quarterly Financial Reports)
Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for CEL SCI CORP stock analysis.
Loading fundamental data...
Loading CEL SCI CORP comprehensive fundamental analysis and insider trading data...
Latest CEL SCI CORP Stock News & Market Analysis
Breaking news, analyst reports, and market updates affecting CEL SCI CORP (CVM) stock price and investment outlook.
CEL-SCI Corp. (AMEX: NYSE:CVM) released news last week that pretty much went unnoticed by investors during a very rough negative trending market, this judging by the non-reaction of the company's ...
CEL-SCI Corporation (NYSE American: CVM) today reported financial results for the quarter ended December 31, 2022, as well as key clinical and corpora ...
CEL-SCI Corporation shares are trading lower by 13.9% Friday morning. The company priced an offering of 3.875 million shares. Historic Summer Setup: 3 "Power Patterns" Triggering in the next 75 ...
Biotech firm CEL-SCI Corporation, a cancer immunotherapy company with operations in Elkridge and Baltimore, Monday announced the pricing of a best-efforts offering of 10.845 million shares of its ...
Cel-Sci Corporation CVM shares are trading lower premarket on Monday. On Sunday, the company disclosed a public offering of 16.13 million shares of common stock or pre-funded warrants at $0.31 per ...
VIENNA, Va. (AP) — VIENNA, Va. (AP) — Cel-Sci Corp. (CVM) on Friday reported a loss of $7.1 million in its fiscal first quarter. The Vienna, Virginia-based company said it had a loss of 11 ...
(RTTNews) - CEL-SCI Corp. (CVM), a Phase 3 cancer immunotherapy company, announced the pricing of a public offering of 16.13 million shares of its common stock. Each share of common stock is being ...
CEL-SCI Corporation today announced it has completed the expansion of its existing dedicated Multikine* cGMP manufacturing facility. Following an $11 million investment to increase production, CEL ...
CEL-SCI raised approximately $27.0 million in gross proceeds during the nine months ended June 30, 2020 through the sale of common stock through public offerings and the exercise of warrants.
CEL SCI CORP Competitors & Peer Analysis - Life Sciences Sector
Comparative analysis of CEL SCI CORP against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.
Frequently Asked Questions - CEL SCI CORP Stock Forecast
How accurate are CEL SCI CORP stock predictions?
Our AI model demonstrates 35% historical accuracy for CVM predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
What factors influence CEL SCI CORP stock price forecasts?
Our analysis considers CEL SCI CORP's financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.
Is CEL SCI CORP a good investment in 2025?
Based on our AI analysis, CEL SCI CORP shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.
How often are CEL SCI CORP forecasts updated?
CEL SCI CORP stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.
Want More Advanced CEL SCI CORP Analysis?
Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for CEL SCI CORP stock.
